SB 239063 is a research compound that acts as an inhibitor of mitogen-activated protein kinase (MAP kinase). It is an imidazole derivative substituted with 4-hydroxycyclohexyl, 4-fluorophenyl, and 2-methoxypyrimidin-4-yl groups.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing SB 239063?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Sodium 1H-imidazole-4-sulfinate
research compound
4-Chloropyridine-2-sulfurpentafluoride
research compound
4-Bromopyridine-2-sulfurpentafluoride
research compound
2-BROMO-5-CHLORO-1,1'-BIPHENYL
research compound
4-[4-(4-fluorophenyl)-5-(2-methoxypyrimidin-4-yl)imidazol-1-yl]cyclohexan-1-ol
ZQUSFAUAYSEREK-UHFFFAOYSA-N
COC1=NC=CC(=N1)C2=C(N=CN2C3CCC(CC3)O)C4=CC=C(C=C4)F
Sourcing SB 239063?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.